Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology ... ( SAN DIEGO California April 11 /- ...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> BIOLOGY >> TECHNOLOGY

Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology R&D Assets

Date:4/11/2008

SAN DIEGO, California, April 11 /PRNewswire/ --

- Newly Established Organization Presents Data on Advancing Compounds at AACR -

Ortho Biotech Oncology Research & Development (ORD), a unit of Johnson & Johnson Pharmaceutical Research & Development, L.L.C., will announce results from studies of three innovative compounds--Hdm2, c-Met, and HDAC inhibitors --here at the American Association for Cancer Research (AACR) 2008 Annual Meeting.

"ORD is a new research and development organization that unites the biotechnology and pharmaceutical oncology efforts of several Johnson & Johnson companies with the goal of transforming cancer into a chronic or curable disease," said William Hait, M.D., Senior Vice President and Worldwide Head of Ortho Biotech Oncology Research & Development. "The new organization harnesses broad, multi-disciplinary capabilities and expertise in order to prioritize existing and emerging opportunities, align cancer treatment with modern cancer biology and improve patients' lives."

ORD's scientific approach to cancer examines the cancer cell and the surrounding tissue, or microenvironment. Previously, researchers often studied cancer as collections of malignant cells growing in isolation, but now understand cancer cells depend on interactions with the surrounding tissue to survive, grow and metastasize. ORD seeks to identify compounds which can inhibit or block the interaction cancer cells have with the surrounding tissues, which compromises the cancer's ability to survive.

The organization will combine the microenvironment disruptive agents (MDAs) resulting from this approach with classic treatments that directly target cancer cells. MDAs represent one of the most promising areas of drug discovery, and ORD has a pipeline of several investigational MDAs, including some of which are first-in-class and first-in-clinic.

Pre-clinical data presented at this year's AACR meeting demonstrate evidence of broad-spec
'/>"/>

SOURCE Ortho Biotech
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5
Related biology technology :

1. Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa)
2. Osteotech to Present at the Canaccord Adams Small-Cap Orthopedics Conference in San Francisco
3. ROBODOC(R) Emerges as a Curexo Technology Company at Upcoming Orthopaedic Surgeons Conference in San Francisco
4. NuVasive to Present at Canaccord Adams Small-Cap Orthopedics Conference
5. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
6. Ortho Biotech Statement On JAMA Publication Regarding Erythropoiesis-Stimulating Agents
7. Symmetry Medical to Present at Canaccord Adams Small-Cap Orthopedics Conference
8. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
9. Barr and Ortho Womens Health & Urology in Discussions to Settle ORTHO TRI-CYCLEN(R) LO Patent Litigation
10. Progentix Orthobiology B.V. Closes Series A Financing Round
11. Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) Label Reflects Recommendations from Recent FDA Advisory Committee Meetings

Post Your Comments:

(Date:11/27/2009)....,Nov.27/PRNewswire/--CromozInc.,locatedinResearch...be-basedcancerdrugdeliverysysteminHyderabad,India....lgroupsonthewallsthatallowsforconjugationwithcance...tuteofKanpur(ITT).Theconjugatedcarbonnanotubesserv...ancersitewhichhasthepotentialtoincreasethedrugeffi...

(Date:11/27/2009)...mber27/PRNewswire-FirstCall/--Stallergeneshasbeen,...ltsandchildren,throughaMutualRecognitionProcedure....eted,wasthereferenceMemberstate. , Oralair(R)...he,CzechRepublic,Estonia,France,Germany,Greece,Hun...lta,theNetherlands,Poland,Portugal,Romania,Slovak...

(Date:11/27/2009)... A mechanised blue dye test alternative i...uality assurance one step closer for pharma-compan...sting machine developed by Sepha for use with b...several local and global pharma-companies such as ... assurance and productivity improvements on the pa...

(Date:11/26/2009)...TE, Ind. - A new generation of ultrasmall transist...ructures called semiconducting nanowires are close...at IBM, Purdue University and the University of Ca...learned how to create nanowires with layers of dif...tomic level, which is a critical requirement for m...

Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2 STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2 STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3 Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2 Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3 Nanowires key to future transistors, electronics 2 Nanowires key to future transistors, electronics 3

[0] North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India [0] STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe [0] Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance [0] Nanowires key to future transistors, electronics

...international team that includes University of Cal...osits around the world including in Albertas oil ...e reservoir. , Their discovery published in the ...onize heavy oil and oil sands production by leadin...ly ways to produce this valuable resource. , Unde...

... Quarter Highlights:, -- Record revenues of $82.0... quarter -- Non... Non-GAAP earnings per share of $0.23, a 130% incr...P earnings per share, -- Operating cash flow of $2...Launch of four new food and beverage products and ...

...EGO, Dec. 12 Arena Pharmaceuticals,Inc. (Nasdaq: ...and Randall,E. Woods were appointed to its board o...,s seventh and eighth independent directors and br...ry operations and management,experience to Arena,s...Mr.,Schneider to its Audit Committee and Mr. Woods...

Making gas out of crude oil Martek Announces Fourth Quarter and FY 2007 Financial Results Arena Pharmaceuticals Appoints Phillip M. Schneider and Randall E. Woods to Board of Directors

(Date:11/26/2009)... Hammerhead sharks are some of the Ocean,s most d...d why they have this strange head shape, says Mic... possible reason is the shark,s vision. ,Perhaps t... head shape, says McComb, giving the sharks excel...ccording to McComb, there were two schools of thou...

(Date:11/26/2009)... Prized for their impressive antlers, red deer ha...ons. But a deer,s antlers are much more than decor...gether when duelling. John Currey, from The Univer...ical properties of bone for over half a century an...es of antler through a long-standing collaboration...

(Date:11/26/2009)... Ecologists have at last worked out a way of usin... size of bird populations. This is the first time ... translated into accurate estimates of bird specie...d in the British Ecological Society,s Journal of ...it could lead to a major advance in our ability to...

Breaking Biology News(10 mins):Wide heads give hammerheads exceptional stereo view 2 Tough yet stiff deer antler is materials scientist's dream 2 Ecologists sound out new solution for monitoring cryptic species 2 After Effects of Chemotherapy May Include Memory Problems 58166 1 After Effects of Chemotherapy May Include Memory Problems 58166 2 VA Honors Eye Researchers With Olin Teague Award 58162 1 VA Honors Eye Researchers With Olin Teague Award 58162 2 12 Local Athletes and Coaches Chosen for U S Wheelchair Basketball Team 58158 1 12 Local Athletes and Coaches Chosen for U S Wheelchair Basketball Team 58158 2

[1] Wide heads give hammerheads exceptional stereo view [1] Tough yet stiff deer antler is materials scientist's dream [0] Ecologists sound out new solution for monitoring cryptic species

...an. 29 Entrust, Inc. (Nasdaq: ENTU ), a world l...on, today announced financial results for its fisc...Fourth-Quarter 2008 , , , , Total reven...7; total revenues were impacted by a strong U.S. d... adjusting for currency , Product revenues ...

... Jan. 29, 2009 At every university, there are fac...anent marks on their students. Few, however, manag...elationships with the longevity and consistency of... Luss, whose legacy will be honored this week at ...day, has spent more than four decades researching ...

...NSING, Mich. -- Knowledge gaps continue to hobble ...igan State University researcher and colleagues wa...wn from what they do know and could help set the g...come. , A worldwide 2005 Millennium Ecosystem Ass... a view of ecosystems through the lens of services...

Entrust Announces Financial Results for Fourth-Quarter and Fiscal 2008 Dinner, lecture series to honor legacy of distinguished UH professor What we don’t know still hurts us, environmental researchers warn

Distillation Hood from Terra Universal, Inc.

Endotoxin Gel formation Assay Kit, E-TOXATE from Sigma-Aldrich

...l safety labs (BSL) and pharmaceutical application... easy sterilization. Panels are precision-joined t...pe down and disinfect. One-inch radius corners sim...eates strong, rigid surface without external braci...

Stainless Steel Glove Boxes from Terra Universal, Inc.

Biology Products:

Distillation Hood from Terra Universal, Inc.Endotoxin Gel formation Assay Kit, E-TOXATE from Sigma-Aldrich BioSafe Clean Room; Powder-Coated CR Steel from Terra Universal, Inc.Stainless Steel Glove Boxes from Terra Universal, Inc.

Ortho Biotech Oncology Research & Development Unites Johnson & Johnson Biopharmaceutical Oncology ...( SAN DIEGO California April 11 /- ...)